NVS Projected Dividend Yield
ADR (Sponsored)/Novartis AG Basel ( NYSE : NVS )Novartis is a holding company. Through its subsidiaries, Co. is a multinational group of companies focusing on the research, development, manufacturing and marketing of a range of pharmaceuticals and generic medicines. Co. comprises two divisions: Innovative Medicines, which researches, develops, manufactures, distributes and sells patented pharmaceuticals; and Sandoz, which develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients, and has three franchises, Retail Generics, Anti-Infectives and Biopharmaceuticals. 29 YEAR PERFORMANCE RESULTS |
NVS Dividend History Detail NVS Dividend News NVS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2023 |
N/A |
Mar 09, 2023 |
Mar 10, 2023 |
Mar 20, 2023 |
2.2742 |
2023 Total: |
2.2742 |
||||
2022 |
N/A |
Mar 08, 2022 |
Mar 09, 2022 |
Mar 17, 2022 |
2.1614 |
2022 Total: |
2.1614 |
||||
2021 |
N/A |
Mar 04, 2021 |
Mar 05, 2021 |
Mar 15, 2021 |
2.0794 |
2021 Total: |
2.0794 |
||||
2020 |
N/A |
Mar 03, 2020 |
Mar 04, 2020 |
Mar 12, 2020 |
2.0068 |
2020 Total: |
2.0068 |
||||
2019 |
N/A |
Mar 04, 2019 |
Mar 05, 2019 |
Mar 13, 2019 |
1.8422 |
2019 Total: |
1.8422 |